Detariffing in the non-life insurance market may well be the beginning of the end of cross-subsidisation and low premiums in group health insurance, with insurers now looking at pricing all their products individually.
Last year, the loss incurred by all insurance companies put together was close to Rs 400 crore (Rs 4 billion) with the claim ratio mounting each year. So, though detariffing may spell good news for insurance companies in the group health portfolio, corporates will have to rethink their strategy.
Before detariffing came into play, group health insurance policies were priced based on the risk profile of the overall insurance portfolio of the corporate, leading to cross-subsidisation.
"Now, in the detariffed regime, all products will be priced individually so the losses in the health insurance portfolio get curtailed," says Ajit Narain, managing director and CEO, IIFCO-TOKIO General Insurance.
This may even mean a hike in the premiums for group health insurance In fact, companies like Bajaj Allianz, besides pricing health insurance on a standalone basis will also work closely with the clients to try and control claims through tie-ups with various hospitals.
This is possible because Bajaj Allianz has an in-house health administration team to administer health insurance claims and is thus not dependent on any third party administrator or TPA.
Worth Rs 1,400 crore (Rs 14 billion) today, group health insurance, a non-profit portfolio for insurers, was until now being cross-subsidised with assumed profitable portfolios.
However, with the likely competition that detariffing will bring to non-life